UBS AM
CNMD icon

UBS AM’s CONMED CNMD Stock Holding History

UBS AM’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Sell
72,034
-283
-0.4% -$10.2K ﹤0.01% 1969
2026
Q1 		$2.56M Buy
72,317
+626
+0.9% +$25.5K ﹤0.01% 1923
2025
Q4 		$2.91M Buy
71,691
+3,746
+6% +$163K ﹤0.01% 1726
2025
Q3 		$3.2M Sell
67,945
-45,118
-40% -$2.34M ﹤0.01% 1568
2025
Q2 		$5.89M Buy
113,063
+30,377
+37% +$1.67M ﹤0.01% 1635
2025
Q1 		$4.99M Buy
82,686
+4,565
+6% +$294K ﹤0.01% 1578
2024
Q4 		$5.35M Buy
78,121
+11,059
+16% +$771K ﹤0.01% 1571
2024
Q3 		$4.82M Buy
67,062
+1,095
+2% +$77.3K ﹤0.01% 1591
2024
Q2 		$4.57M Sell
65,967
-59,262
-47% -$4.32M ﹤0.01% 1540
2024
Q1 		$10M Sell
125,229
-4,990
-4% -$445K ﹤0.01% 993
2023
Q4 		$14.3M Buy
130,219
+15,398
+13% +$1.59M 0.01% 872
2023
Q3 		$11.6M Buy
114,821
+84,572
+280% +$9.72M 0.01% 912
2023
Q2 		$3.14M Hold
30,249
– – ﹤0.01% 1428
2023
Q1 		$3.14M Sell
30,249
-578
-2% -$55.9K ﹤0.01% 1428
2022
Q4 		$2.73M Hold
30,827
– – ﹤0.01% 1398
2022
Q3 		$2.47M Sell
30,827
-2,957
-9% -$279K ﹤0.01% 1493
2022
Q2 		$3.24M Sell
33,784
-261
-0.8% -$31.3K ﹤0.01% 1395
2022
Q1 		$5.06M Buy
34,045
+609
+2% +$85K ﹤0.01% 1346
2021
Q4 		$4.74M Sell
33,436
-491
-1% -$69.5K ﹤0.01% 1433
2021
Q3 		$4.44M Sell
33,927
-433
-1% -$56.6K ﹤0.01% 1405
2021
Q2 		$4.72M Sell
34,360
-164
-0.5% -$22.5K ﹤0.01% 1398
2021
Q1 		$4.51M Buy
34,524
+155
+0.5% +$18.7K ﹤0.01% 1382
2020
Q4 		$3.85M Sell
34,369
-932
-3% -$88.2K ﹤0.01% 1400
2020
Q3 		$2.78M Buy
35,301
+3,803
+12% +$310K ﹤0.01% 1406
2020
Q2 		$2.27M Sell
31,498
-2,310
-7% -$161K ﹤0.01% 1468
2020
Q1 		$1.94M Sell
33,808
-861
-2% -$79.4K ﹤0.01% 1425
2019
Q4 		$3.88M Buy
34,669
+417
+1% +$44.4K ﹤0.01% 1300
2019
Q3 		$3.29M Buy
34,252
+6,763
+25% +$635K ﹤0.01% 1385
2019
Q2 		$2.35M Buy
27,489
+6,234
+29% +$512K ﹤0.01% 1507
2019
Q1 		$1.77M Buy
21,255
+1,881
+10% +$137K ﹤0.01% 1581
2018
Q4 		$1.24M Buy
19,374
+770
+4% +$52.7K ﹤0.01% 1654
2018
Q3 		$1.47M Buy
18,604
+33
+0.2% +$2.55K ﹤0.01% 1631
2018
Q2 		$1.36M Buy
18,571
+948
+5% +$64.5K ﹤0.01% 1689
2018
Q1 		$1.12M Buy
17,623
+4,963
+39% +$296K ﹤0.01% 1743
2017
Q4 		$645K Hold
12,660
– – ﹤0.01% 1888
2017
Q3 		$664K Buy
12,660
+104
+0.8% +$5.22K ﹤0.01% 1849
2017
Q2 		$640K Buy
12,556
+13
+0.1% +$643 ﹤0.01% 1809
2017
Q1 		$557K Buy
12,543
+4,859
+63% +$209K ﹤0.01% 1831
2016
Q4 		$339K Sell
7,684
-8,615
-53% -$366K ﹤0.01% 1897
2016
Q3 		$653K Hold
16,299
– – ﹤0.01% 1848
2016
Q2 		$778K Hold
16,299
– – ﹤0.01% 1756
2016
Q1 		$684K Sell
16,299
-1,100
-6% -$43.2K ﹤0.01% 1789
2015
Q4 		$766K Hold
17,399
– – ﹤0.01% 1844
2015
Q3 		$831K Hold
17,399
– – ﹤0.01% 1797
2015
Q2 		$1.01M Buy
17,399
+1,700
+11% +$91.7K ﹤0.01% 1674
2015
Q1 		$793K Buy
15,699
+300
+2% +$14.7K ﹤0.01% 1733
2014
Q4 		$692K Hold
15,399
– – ﹤0.01% 1764
2014
Q3 		$567K Hold
15,399
– – ﹤0.01% 1804
2014
Q2 		$680K Buy
15,399
+800
+5% +$36.3K ﹤0.01% 1736
2014
Q1 		$634K Buy
14,599
+3,000
+26% +$134K ﹤0.01% 1743
2013
Q4 		$493K Sell
11,599
-800
-6% -$30.4K ﹤0.01% 1816
2013
Q3 		$421K Hold
12,399
– – ﹤0.01% 1872
2013
Q2 		$387K Buy
+12,399
New +$402K ﹤0.01% 1828

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

UBS AM's CNMD Position: Q2 2026 in Review

UBS AM reduced its CONMED (CNMD) stake by 0.39% in Q2 2026, selling an estimated $10.2K and leaving 72,034 shares worth $2.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1969.

UBS AM first reported a position in CNMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.3M in Q4 2023. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • UBS AM held 72,034 shares of CONMED worth $2.36M as of Q2 2026.
  • UBS AM sold 283 CONMED shares in Q2 2026, an estimated $10.2K.
  • CONMED made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1969 holding.
  • UBS AM first reported a position in CONMED in Q2 2013 and has held it in 53 quarters since.
  • UBS AM's CONMED position peaked at $14.3M in Q4 2023.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.